Malignant Neoplasm of Stomach Unknown Status Phase 2 Trials for Capecitabine (DB01101)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00780494Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric CarcinomaTreatment
NCT01618474Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer PatientsTreatment
NCT00865982Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal CancerTreatment
NCT00985556Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric CancerTreatment
NCT01167049Xeloda Plus Paclitaxel in Gastric Cancer With Liver MetastasisTreatment
NCT01798251XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of StomachTreatment
NCT01963702A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGCTreatment